Synthomer's share price has experienced significant downward pressure over multi-year periods due to a combination of heavy debt loads incurred from past large-scale acquisitions, post-pandemic normalization in medical glove latex demand, rising borrowing costs, and cyclical downturns in global construction and coatings markets. These combined pressures led to compressed profit margins, temporary net losses, and cautious market sentiment while management executes its multi-year operational turnaround and deleveraging strategy.